TeneoTwo

Exited

New therapy for B-cell hematologic malignancies

TeneoTwo is tracked in the Tech.eu funding database. Based in Delaware, United States; active in Healthtech. Acquired by AstraZeneca in 2022. Data as of 21 Aug 2026.

Delaware, United States

Healthtech

← All companies

Total raised

€0

Funding rounds

Investors

distinct backers

Active since

—

Funding rounds

0 rounds

No funding rounds recorded.

Exit

Type

acquisition

Date

Jul 2022

Value

€1.2B

Acquiror

AstraZeneca (UK)

Similar companies

same sector or country

Philips

TeneoTwo

Funding rounds

Exit

Related news

Similar companies